The effectiveness of ENARĀ® for the treatment of chronic neck pain in Australian adults: a preliminary single-blind, randomised controlled trial
2007

Effectiveness of ENAR Therapy for Chronic Neck Pain

Sample size: 24 publication Evidence: moderate

Author Information

Author(s): Andrew L Vitiello, Rodney Bonello, Henry Pollard

Primary Institution: Macquarie University

Hypothesis

Does ENAR therapy result in superior pain reduction and improvements in neck function compared to TENS or control intervention?

Conclusion

ENAR therapy significantly reduced neck pain intensity and disability, and improved function and quality of life compared to TENS and control therapies.

Supporting Evidence

  • ENAR group showed a decrease in mean pain score from 5.0 to 1.75 over 24 weeks.
  • NDI scores for the ENAR group were approximately half that of TENS and control groups.
  • PSFS results indicated significantly better performance for ENAR compared to TENS and control.

Takeaway

People with neck pain who used the ENAR device felt much better than those who used other treatments.

Methodology

A single-blind, randomized controlled trial with 24 participants divided into three groups: ENAR, TENS, and control, assessing pain and disability over 24 weeks.

Potential Biases

Potential bias due to the inability to blind practitioners administering the treatments.

Limitations

The study had a small sample size and lack of blinding for practitioners delivering therapies.

Participant Demographics

24 participants (10 males, 14 females) aged 18 to 50 years, median age 40.5.

Statistical Information

P-Value

0.01

Confidence Interval

95% CI

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1746-1340-15-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication